Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants

Phytomedicine

Volumn 12, Issue 1-2, 2005, Pages 88-92

  Jantan, I ^a   Rafi, I A A ^a   Jalil, J ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Antagonistic activity; Cinnamomum sp.; Malaysian medicinal plants; Platelet activating factor (PAF); Zingiberaceae sp.

Indexed keywords

ALPINIA GALANGA EXTRACT; BOESENBERGIA PANDURATA EXTRACT; CINNAMOMUM ALTISSIMUM EXTRACT; CINNAMOMUM PUBESCENS EXTRACT; CURCUMA AERUGINOSA EXTRACT; CURCUMA OCHORRHIZA EXTRACT; GINGER EXTRACT; GONIOTHALAMUS MALAYANUS EXTRACT; METHANOL; MOMORDICA CHARANTIA EXTRACT; PIPER ADUNCUM EXTRACT; PLANT EXTRACT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; ZINGIBER ZERUMBET EXTRACT;

ANIMAL CELL; ARTICLE; BOESENBERGIA PANDURATA; CINNAMOMUM ALTISSIMUM; CINNAMOMUM PUBESCENS; CONTROLLED STUDY; CURCUMA AERUGINOSA; CURCUMA OCHORRHIZA; DRUG ACTIVITY; GINGER; GONIOTHALAMUS MALAYANUS; IC 50; MEDICINAL PLANT; MOMORDICA CHARANTIA; NONHUMAN; PIPER ADUNCUM; PRIORITY JOURNAL; RABBIT; THROMBOCYTE; ZINGIBER ZERUMBET;

ANIMALS; FRUIT; INHIBITORY CONCENTRATION 50; MALAYSIA; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLANT LEAVES; PLANT STEMS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEIN BINDING; RABBITS; RECEPTORS, G-PROTEIN-COUPLED; RHIZOME; SEEDS; ZINGIBERACEAE;

ALPINIA GALANGA; BOESENBERGIA; BOESENBERGIA PANDURATA; CINNAMOMUM; CURCUMA AERUGINOSA; GONIOTHALAMUS MALAYANUS; KAEMPFERIA GALANGA; MOMORDICA CHARANTIA; ORYCTOLAGUS CUNICULUS; PIPER ADUNCUM; ZINGIBER OFFICINALE; ZINGIBER ZERUMBET; ZINGIBERACEAE;

EID: 12944319340     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2003.06.006     Document Type: Article

References (17)

1. P. Bessin, J. Bonnet, P. Apffel, C. Soulard, L. Desgrou, I. Pelassi, and J. Benveniste Acute circulatory collapse caused by platelet-activating factor in dogs Eur. J. Pharmacol. 86 1983 403 413
2. M.L. Blank, F. Synder, L.W. Byers, B. Brooks, and E.E. Muirhead Antihypertensive activity of an alkyl ether analog of phosphatidylcholine Biochem. Biophys. Res. Commun. 90 1979 1194 1200
3. P. Braquet, L. Tougui, T.Y. Shen, and B.B. Vargaftig Perspectives in platelet activating factor research Pharmacol. Rev. 39 1987 97 145
4. I.H. Burkill A Dictionary of the Economic Products of the Malay Peninsula Vol. 2 1966 Ministry of Agriculture and Cooperatives Kuala Lumpur, Malaysia
5. P. Claeson, U. Pongprayoon, T. Sematong, P. Tuchinada, V. Reutrakul, P. Soontornsarature, and W.C. Tylor Non-phenolic linear diarylheptanoids from Curcuma xanthorrhiza a novel type of tropical anti-inflammatory agents: structure-activity relationship Planta Med. 62 1996 236 240
6. T.W. Doebber, M.S. Wu, J.C. Robbins, B.M. Choy, M.N. Chang, and T.Y. Shen Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats studies with PAF-receptor antagonist, kadsurenone Biochem. Biophys. Res. Commun. 29 1985 799 808
7. P.W. Grosvenor, A. Supriono, and D.O. Gray Medicinal plants from Riau Province, Sumatra, Indonesia. Part 1 antibacterial and antifungal activities J. Ethnopharmacol. 45 1995 75 95
8. W. Hsueh, F. Gonzalez-Crussi, and J.L. Arroyave Platelet activating factor-induced ischemic bowel necrosis Am. J. Pathol. 122 1986 231 239
9. D.M. Humphrey, D.J. Hanahan, and R.N. Pinckard Induction of leucocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine Lab. Invest. 47 1982 227 234
10. O. Ito, G. Camussi, C. Tetta, F. Milgrom, and G. Andress Hyperacute renal allograft rejection in rabbit the role of platelet-activating factor and cationic proteins derived from polymorphonuclear leucocytes and from platelets Lab. Invest. 51 1984 148 161
11. E. Kloprogge, and N. Akkerman Binding kinetic of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets Biochem. J. 233 1984 901 909
12. A.T. Mallet, and F.M. Cunningham Structural identification of platelet activating factor in psoriatic scale Biochem. Biophys. Res. Commun. 126 1985 192 198
13. 3H]platelet-activating factor binding in human platelets J. Pharmacol. Exp. Ther. 252 1990 1221 1227
14. F.H. Valone, E. Coles, V.R. Reinhold, and E.J. Goetzl Specific binding of phospholipid platelet-activating factor by human platelets J. Immunol. 129 1982 1637 1641
15. B.B. Vargaftig, and P.G. Braquet PAF-acether today relevance for acute experimental anaphylaxis Br. Med. Bull. 43 1987 312 335
16. B.B. Vargaftig, M. Chignard, J. Benveniste, J. Lefort, and F. Wal Background and present status of research on platelet-activating factor Ann. NY Acad. Sci. 370 1981 119 137
17. H.K. Yang, D.Y. Suh, and B.H. Han Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis Planta Med. 61 1995 37 40